Vor biopharma inc.

Major-Pharmaceuticals

VOR


Executive/
Director

Price

  • Last Close
  • $ 1.32
    $ +0.21 18.92 %
    Jan 3, 2025
  • 52-Week High/Low
  • $2.85 - $0.81
  • YTD
  • 20%

  • Trading Volume
  • 47,803
  • Market Cap Full
  • $ 89.5M
  • Shares Outstanding
  • 67.8M
    Nov 7, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - - - -49.2% -19.1% 3.1% 20%
Q2 - - - - - -56.7% -17.7% -42.6% -48.2% -
Q3 - - - - - -15.2% -19.9% -31.4% -6.3% -
Q4 - - - - - -24.8% 67.1% 15.1% 31.1% -
J F M A M J J A S O N D
2025 20% - - - - - - - - - - -
2024 2.2% - 0.9% -26.3% -21.6% -14.2% -20% -6.3% - - - 33.7%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%0%-44%-66%-51%20%

Earnings

2021 2022 2023
Q1 -0.67 -0.61 -0.43
Q2 -0.5 -0.58 -0.45
Q3 -0.5 -0.63 -0.49
Q4 -0.49 -0.53 -
A -2.1 -2.3 -1.37

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 37.5 66.4
Jun 37.1 37.6 67
Sep 37.1 38.1 67.5
Dec 37.3 38.7 67.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - - - -
Equity multiplier - - - - -